Data from: Microvascular rarefaction in the sinoatrial node
Data files
Dec 12, 2025 version files 250.11 MB
-
20241210-HCN4-CD31-10X-Tile.tif
171.43 MB
-
20241210-HCN4-CD31-20X-Tile.tif
48.39 MB
-
20241210-HCN4-CD31-iSAN-60X.tif
15.13 MB
-
20241210-HCN4-CD31-sSAN-60X.tif
15.16 MB
-
README.md
2.47 KB
Abstract
This study tested the hypothesis that sinoatrial node microvascular rarefaction occurs in a model of heart failure with preserved ejection fraction (HFpEF). While it has been established that the sinoatrial node exhibits vascular heterogeneity, it was not known whether microvessel density changes regionally or is altered overall during HFpEF. Data provided here demonstrates vascular and pacemaker cell densities under normal conditions with representations at low and high magnifications.
Dataset DOI: 10.5061/dryad.k98sf7mmp
Description of the data and file structure
This dataset contains immunofluorescent images of the cardiac sinoatrial node labeled with antibodies against HCN4 and CD31. HCN4 labels cardiac pacemaker cells, and CD31 labels endothelial cells. Images were taken at 10X, 20X, and 60X. For images taken at 10X, the entire cardiac sinoatrial node is visualized along with surrounding tissue, including the right atrial appendage, superior vena cava, and inferior vena cava. Multiple images are taken and stitched together. For the 20X image, just the region encompassing the cardiac sinoatrial node is acquired, where multiple tiled images are stitched together. For the 60X images, single areas of the superior (sSAN) or inferior (iSAN) sinoatrial nodes were acquired.
Files and variables
File: 20241210-HCN4-CD31-10X-Tile.tif
Description: Cardiac sinoatrial node tissue immunofluorescently labeled with antibodies against HCN4 (HCN4-expressing pacemaker cells) and CD31 (endothelial cells in the endocardium and vascular endothelium). Image taken at 10x magnification and tiled to image the entire sinoatrial node.
File: 20241210-HCN4-CD31-20X-Tile.tif
Description: Cardiac sinoatrial node tissue immunofluorescently labeled with antibodies against HCN4 (HCN4-expressing pacemaker cells) and CD31 (endothelial cells in the endocardium and vascular endothelium). Image taken at 20x magnification and tiled to image the entire sinoatrial node.
File: 20241210-HCN4-CD31-iSAN-60X.tif
Description: Inferior region of the cardiac sinoatrial node tissue immunofluorescently labeled with antibodies against HCN4 (HCN4-expressing pacemaker cells) and CD31 (endothelial cells in the endocardium and vascular endothelium). Image taken at 60x magnification of a sub-region of the node.
File: 20241210-HCN4-CD31-sSAN-60X.tif
Description: Superior region of the cardiac sinoatrial node tissue immunofluorescently labeled with antibodies against HCN4 (HCN4-expressing pacemaker cells) and CD31 (endothelial cells in the endocardium and vascular endothelium). Image taken at 60x magnification of a sub-region of the node.
Code/software
Open-source software, such as ImageJ/FIJI, can be used to view the data. Images can be opened directly in ImageJ/FIJI using the Bioformats plugin.
Whole-Mount Immunohistochemistry
Following confirmation of isoflurane anesthesia, we rapidly excised hearts and placed them in prewarmed (37 °C) heparinized (0.2 mg/mL) Tyrode III solution (in mM: 140 NaCl, 5.4 KCl, 1.0 MgCl₂, 1.8 CaCl₂, 5.0 HEPES, and 10 d-glucose, pH adjusted to 7.4 with NaOH). We then dissected the SAN and surrounding regions, including portions of the right atrial appendage, superior vena cava, and inferior vena cava. We pinned and stretched the tissues in a 35 mm Sylgard-coated dish, rapidly rinsed them three times in phosphate-buffered saline (PBS), and fixed them in 2 mL of 4% paraformaldehyde (0.01 M PBS) for 1 hour at room temperature. After fixation, we washed the tissues three times with PBS and transferred them to a 50 mL tube containing PBS for 12 hours at 4°C. We performed tissue dehydration, bleaching, and clearing in dimethyl sulfoxide (DMSO) to reduce tissue autofluorescence, as previously described [PMID: 25262932, 16806289]. Briefly, we dehydrated tissues through an EtOH gradient (25, 50, 75, 95, 100%), cleared for 2 hours in 20% DMSO in EtOH, and bleached tissues for 12 hours in 6% hydrogen peroxide in EtOH. We achieved rehydration via a reverse ethanol gradient, followed by three 10-minute PBS washes. We permeabilized tissues with 0.5% Triton X-100 in PBS (3 x 10min). We blocked non-specific binding with 5% normal donkey serum in 0.5% Triton X-100 PBS for 2 hours. After PBS washes (3 x 10min), we incubated the tissues for 48 hours at 4 °C in a 200μL volume of primary antibody cocktail, which included: goat anti-mouse CD31 (1:50; AF3628, R&D Systems) and rabbit anti-mouse HCN4 (1:200; ab289962, Abcam) diluted in PBS. We washed primary antibodies three times in PBS followed by incubation in 1 mL of secondary antibodies cocktail containing donkey anti-goat Alexa Fluor 488 (1:1000, ab150129, Abcam), and donkey anti-rabbit Alexa Fluor 594, (1:1000, ab150076; Abcam) for 3 hours at room temperature with minimal light exposure. After labeling, we washed tissues in PBS, and incubated them for 2 hours in a 25% DMSO PBS solution. We then mounted tissues in Vectashield vibrance medium (Vector Laboratories) with a coverslip and allowed mounting media hardening for 12 hours before acquiring images.
Immunohistochemistry Image Acquisition
For confocal tissue imaging, we used an inverted Leica Stellaris 5 microscope (Leica Microsystems, Wetzlar, Germany) equipped with 10x objective (Leica HC PL APO 10x, NA 0.40 CS2) for imaging the entire dissected tissue, 20x objective (Leica HCX PL FL 20x, NA 0.40 CS2) for focusing on the entire SAN region and, 63x oil-immersion objective (Leica HC PL APO 63x, NA = 1.4 Oil CS2) for specific sSAN and iSAN regions. We captured sSAN and iSAN images at 0.18 x 0.18x 0.30 μm/pixel resolution (231 μm2 field of view) using Leica Application Suite X (LAS X) software. We acquired Z-stacks to span the entire SAN tissue depth (approximately 406 Z-planes). We used the LAS X Navigator to perform stitching with an overlap of approximately 15%.
